Detalles de la búsqueda
1.
Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.
J Clin Oncol
; 27(15): 2474-81, 2009 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-19332727
Resultados
1 -
1
de 1
1
Próxima >
>>